TrademarkOpen
Search / United States / 88844359

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

CELLFE

Registered
Used for: Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment…
Show more

Class 5: Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for the prevention of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; Living cells for treating medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, autoimmune diseases; Living cells for medical purposes, namely, for creating cell therapies
Class 9: Laboratory apparatus in the nature of microfluidic chips for scientific research for use in the delivery of macromolecules, nanoparticles, or polymers to cells; Laboratory apparatus kits comprising microfluidic chips and a pressurized gas system comprised of flow control instruments, gas supply, flow channels, and containers, vessels for scientific research; Laboratory apparatus kits comprising microfluidic chips and pumping systems comprised of flow control instruments, flow pumps, flow channels, and containers, vessels for scientific research
Class 10: Medical apparatus in the nature of microfluidic chips for use in cell therapy and immunotherapy for use in the delivery of macromolecules, nanoparticles and polymers to cells; Medical apparatus in the nature of a kit comprising microfluidic chips, a control apparatus, and a pressurized gas system comprised of flow control instruments, gas supply, flow channels, and containers, vessels for delivery of cell therapy, immunotherapy, medical treatments, and diagnostics; Medical equipment in the nature of a kit comprising microfluidic chips, a control apparatus, and a pumping system comprised of flow control instruments, flow pumps, flow channels, and containers, vessels for delivery of cell thera…

Class 5 – Pharmaceuticals & supplementsClass 9 – Software, electronics & scientificClass 10 – Medical apparatus

Status timeline

  1. 26 Mar 2020
    Application filed
    New Application Entered
  2. 14 Jun 2020
    Assigned to an examining attorney
    Assigned To Examiner
  3. 15 Jun 2020
    Office action issued
    Non-Final Action Written
  4. 4 Nov 2020
    Response to office action filed
    Teas Response To Office Action Received
  5. 16 Dec 2020
    Approved for publication
    Approved For Pub - Principal Register
  6. 19 Jan 2021
    Published for opposition
    Published For Opposition
  7. 16 Mar 2021
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 15 Sep 2021
    Statement of use filed
    Teas Statement Of Use Received
  9. 16 Oct 2021
    Office action issued
    Non-Final Action Written
  10. 21 Oct 2021
    Response to office action filed
    Teas Response To Office Action Received
  11. 9 Nov 2021
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  12. 10 Nov 2021
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  13. 14 Dec 2021
    Registered on the Principal Register
    Registered-Principal Register
All 34 events
2024-12-31Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-12-31Attorney/Dom.rep.revoked And/Or Appointed
2024-12-31Teas Change Of Correspondence Received
2021-12-14Registered-Principal Register
2021-11-10Notice Of Acceptance Of Statement Of Use E-Mailed
2021-11-09Allowed Principal Register - Sou Accepted
2021-10-22Teas/Email Correspondence Entered
2021-10-21Teas Response To Office Action Received
2021-10-21Correspondence Received In Law Office
2021-10-16Non-Final Action Written
2021-10-16Non-Final Action E-Mailed
2021-10-16Notification Of Non-Final Action E-Mailed
2021-09-27Case Assigned To Intent To Use Paralegal
2021-09-27Statement Of Use Processing Complete
2021-09-15Teas Statement Of Use Received
2021-09-15Use Amendment Filed
2021-03-16Noa Mailed - Sou Required From Applicant
2021-01-19Published For Opposition
2021-01-19Official Gazette Publication Confirmation E-Mailed
2020-12-30Notification Of Notice Of Publication E-Mailed
2020-12-16Examiners Amendment -Written
2020-12-16Examiners Amendment E-Mailed
2020-12-16Notification Of Examiners Amendment E-Mailed
2020-12-16Examiner's Amendment Entered
2020-12-16Approved For Pub - Principal Register
2020-11-05Teas/Email Correspondence Entered
2020-11-04Teas Response To Office Action Received
2020-11-04Correspondence Received In Law Office
2020-06-15Non-Final Action Written
2020-06-15Non-Final Action E-Mailed
2020-06-15Notification Of Non-Final Action E-Mailed
2020-06-14Assigned To Examiner
2020-03-26New Application Entered
2020-03-26New Application Office Supplied Data Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for the prevention of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; Living cells for treating medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, autoimmune diseases; Living cells for medical purposes, namely, for creating cell therapies

First use anywhere 9 Aug 2021 · First use in commerce 9 Aug 2021

Class 9 Software, electronics & scientific

Laboratory apparatus in the nature of microfluidic chips for scientific research for use in the delivery of macromolecules, nanoparticles, or polymers to cells; Laboratory apparatus kits comprising microfluidic chips and a pressurized gas system comprised of flow control instruments, gas supply, flow channels, and containers, vessels for scientific research; Laboratory apparatus kits comprising microfluidic chips and pumping systems comprised of flow control instruments, flow pumps, flow channels, and containers, vessels for scientific research

First use anywhere 9 Aug 2021 · First use in commerce 9 Aug 2021

Class 10 Medical apparatus

Medical apparatus in the nature of microfluidic chips for use in cell therapy and immunotherapy for use in the delivery of macromolecules, nanoparticles and polymers to cells; Medical apparatus in the nature of a kit comprising microfluidic chips, a control apparatus, and a pressurized gas system comprised of flow control instruments, gas supply, flow channels, and containers, vessels for delivery of cell therapy, immunotherapy, medical treatments, and diagnostics; Medical equipment in the nature of a kit comprising microfluidic chips, a control apparatus, and a pumping system comprised of flow control instruments, flow pumps, flow channels, and containers, vessels for delivery of cell thera…

First use anywhere 9 Aug 2021 · First use in commerce 9 Aug 2021

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 31 Dec 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.